Jazz Pharmaceuticals JAZZ Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's income taxes at U.S. statutory rate of 21%?
- Jazz Pharmaceuticals (JAZZ) reported income taxes at U.S. statutory rate of 21% of 12.5% in Q4 2025.
- What does income taxes at U.S. statutory rate of 21% mean?
- The base tax amount calculated using the U.S. federal statutory rate.
- How do you interpret income taxes at U.S. statutory rate of 21%?
- Changes in this value primarily track fluctuations in pre-tax income rather than changes in tax strategy.
- How does income taxes at U.S. statutory rate of 21% compare across companies?
- Consistent across all U.S.-based or U.S.-reporting entities.